Dr. Charlotte L. Baker, MD

Dr. Baker practices at The Guidance Center - Behavioral Health Urgent Care in Southgate, Michigan.

Dr. Baker's NPI, 1851556708, was assigned on July 21, 2008. Dr. Baker holds Indiana license 01066919A.

Dr. Baker's primary practice is The Guidance Center - Behavioral Health Urgent Care, at 19291 Northline Road, Southgate, MI 48195. The practice phone is (734) 287-1500.

Dr. Baker's primary practice is The Guidance Center - Behavioral Health Urgent Care in Southgate, Michigan. The medical group on file is The Guidance Center. Dmand AI also links Dr. Baker to 1 more group practice or clinic, named with a free account. Dr. Baker's employer is on file too: a behavioral health center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baker practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Baker's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Baker is licensed in Indiana.

CMS data shows 120 Medicare services from Dr. Baker across 1 procedure code in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $2,533 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Baker in 2024. 72% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baker's median patient age at 56, with 64% women.

In 2024, Dr. Baker wrote 4,727 Medicare Part D claims for 148 patients. 90% of them were for generic drugs. CMS names the drug for 4,630 of them, across 71 drugs with 11 or more claims each, at $621,077 in total drug cost. In 2023, CMS named 5,786 claims across 75 drugs.

Dr. Baker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baker as offering telehealth.

CMS Open Payments shows 114 general payments to Dr. Baker from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alkermes, Inc. paid the most, $361.